Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danny Liew

Showing results (101-110 of 481) with videos related to

Pageof 49
Sort By:
BMC Public Health|August 16, 2011
Estimating the lifetime economic burden of stroke according to the age of onset in South Korea: a cost of illness studyHye-Young Kang, Seung-Ji Lim, Hae Sun Suh, et al.
Disability and Health Journal|January 13, 2023
Estimating the impact of Angelman syndrome on parental productivity in Australia using productivity-adjusted life yearsSally L Sansom, Emma K Baker, David E Godler, et al.
International Journal of Cardiology|January 29, 2019
The cost-effectiveness of canakinumab for secondary prevention of cardiovascular disease: The Australian healthcare perspectiveElla Zomer, Danny Liew, Andrew Tonkin, et al.
Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals|August 3, 2019
A Markov cost-effective analysis of biannual fluoride varnish for preventing dental caries in permanent teeth over a 70-year time horizonTan Minh Nguyen, Utsana Tonmukayakul, Emma Warren, et al.
Circulation. Cardiovascular Quality and Outcomes|October 17, 2022
Cost-Effectiveness of Empagliflozin in Patients With Heart Failure and Preserved Ejection FractionJennifer Zhou, Danny Liew, David M Kaye, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 14, 2021
Cost-Effectiveness of Empagliflozin and Metformin Combination Versus Standard Care as First-Line Therapy in Patients With Type 2 Diabetes MellitusDina Abushanab, Danny Liew, Clara Marquina, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|December 13, 2019
Histidine-containing dipeptides reduce central obesity and improve glycaemic outcomes: A systematic review and meta-analysis of randomized controlled trialsKirthi Menon, Clara Marquina, Danny Liew, et al.
BMJ Open|August 1, 2022
Estimating the economic impact of acute coronary syndrome in New Zealand over time (ANZACS-QI 64): a national registry-based cost burden studyPeter Lee, A J Kerr, Yannan Jiang, et al.
European Journal of Preventive Cardiology|July 23, 2021
The cost-effectiveness of icosapent ethyl in combination with statin therapy compared with statin alone for cardiovascular risk reductionZanfina Ademi, Richard Ofori-Asenso, Ella Zomer, et al.
Studies in Health Technology and Informatics|January 25, 2024
Digital Health for Myocardial Infarction: Research Topics and TrendsMelissa Pelly, Farhad Fatehi, Mahnaz Samadbeik, et al.
Pageof 49

Showing results (101-110 of 481) with videos related to

Sort By:
Pageof 49
BMC Public Health|August 16, 2011
Estimating the lifetime economic burden of stroke according to the age of onset in South Korea: a cost of illness studyHye-Young Kang, Seung-Ji Lim, Hae Sun Suh, et al.
Disability and Health Journal|January 13, 2023
Estimating the impact of Angelman syndrome on parental productivity in Australia using productivity-adjusted life yearsSally L Sansom, Emma K Baker, David E Godler, et al.
International Journal of Cardiology|January 29, 2019
The cost-effectiveness of canakinumab for secondary prevention of cardiovascular disease: The Australian healthcare perspectiveElla Zomer, Danny Liew, Andrew Tonkin, et al.
Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals|August 3, 2019
A Markov cost-effective analysis of biannual fluoride varnish for preventing dental caries in permanent teeth over a 70-year time horizonTan Minh Nguyen, Utsana Tonmukayakul, Emma Warren, et al.
Circulation. Cardiovascular Quality and Outcomes|October 17, 2022
Cost-Effectiveness of Empagliflozin in Patients With Heart Failure and Preserved Ejection FractionJennifer Zhou, Danny Liew, David M Kaye, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 14, 2021
Cost-Effectiveness of Empagliflozin and Metformin Combination Versus Standard Care as First-Line Therapy in Patients With Type 2 Diabetes MellitusDina Abushanab, Danny Liew, Clara Marquina, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|December 13, 2019
Histidine-containing dipeptides reduce central obesity and improve glycaemic outcomes: A systematic review and meta-analysis of randomized controlled trialsKirthi Menon, Clara Marquina, Danny Liew, et al.
BMJ Open|August 1, 2022
Estimating the economic impact of acute coronary syndrome in New Zealand over time (ANZACS-QI 64): a national registry-based cost burden studyPeter Lee, A J Kerr, Yannan Jiang, et al.
European Journal of Preventive Cardiology|July 23, 2021
The cost-effectiveness of icosapent ethyl in combination with statin therapy compared with statin alone for cardiovascular risk reductionZanfina Ademi, Richard Ofori-Asenso, Ella Zomer, et al.
Studies in Health Technology and Informatics|January 25, 2024
Digital Health for Myocardial Infarction: Research Topics and TrendsMelissa Pelly, Farhad Fatehi, Mahnaz Samadbeik, et al.
Pageof 49